Geographical similarity and differences in the burden and genetic predisposition of NAFLD-Reference-Cited by-同舟云学术

Geographical similarity and differences in the burden and genetic predisposition of NAFLD

Published:2022-10-11 Issue:4 Volume:77 Page:1404-1427
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Yip Terry Cheuk‐Fung,Vilar‐Gomez Eduardo,Petta Salvatore,Yilmaz Yusuf,Wong Grace Lai‐Hung,Adams Leon A.,de Lédinghen Victor,Sookoian Silvia,Wong Vincent Wai‐Sun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32774

Reference218 articles.

1. Non‐alcoholic fatty liver disease;Lancet,2021

2. Worldwide trends in body‐mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population‐based measurement studies in 128.9 million children, adolescents, and adults;Lancet,2017

3. Rising rural body‐mass index is the main driver of the global obesity epidemic in adults;Nature,2019

4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016‐2030;J Hepatol,2018

5. Modelling NAFLD disease burden in four Asian regions‐2019–2030;Aliment Pharmacol Ther,2020

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification;Ultrasound in Medicine & Biology;2024-08

2. Adherence to a healthy lifestyle including sleep and sedentary behaviors and risk of metabolic dysfunction-associated steatotic liver disease in Chinese adults;Preventive Medicine;2024-07

3. FGF1-based Drugs for The Treatment of Obesity-related Complications;PROG BIOCHEM BIOPHYS;2024

4. Resmetirom for treatment of MASH;Cell;2024-06

5. Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology;European Journal of Internal Medicine;2024-06